Else Kröner Forschungskollegs 2025 (only available in German)

Zurzeit wählen jedoch immer noch zu wenige Ärztinnen und Ärzte diesen Berufsweg.

Die Else Kröner-Fresenius-Stiftung möchte die Medizinischen Fakultäten und Universitätsklinika in Deutschland im Rahmen von Kollegs unterstützen, ihren wissenschaftlich hochtalentierten jungen Ärztinnen und Ärzten ein optimales Umfeld zur Vertiefung ihrer Forschungsarbeit und zum Einstieg in einen erfolgreichen Berufsweg als Clinician Scientist zu ermöglichen.

Reentry after parental leave or supervisory care phase made easier

Bad Homburg v. d. Höhe, 14. Januar 2025 – In 2024 Else Kröner-Fresenius-Stiftung (EKFS) once again awarded funding within the scope of the Else Kröner Clinician Scientist Return-To-Work Grant program. Through individually deployable financial resources amounting to up to 400,000 euros in each case, the foundation supports particularly successful physicians who want to return to the clinic and research following a lengthier pause to attend to their families.

Estrogen counteracts increased infarct size and cardiac remodelling in post-menopause women with T2D and MI

Type 2 diabetes mellitus (T2D) leads to an increased infarct size in postmenopausal women. The G protein-coupled estrogen receptor (GPER) may be decisive here. This oestrogen receptor mediating rapid non-genomic effects. Its expression is reduced both during menopause and in T2D. This is of great relevance as GPER is protective in myocardial infarction. We hypothesize that estrogen as a GPER activator in the infarct is therefore a potential therapeutic target. This will be investigated in murine analyses in the menopausal model with T2D and infarction.

Sensing in motion - The role of sensory systems in cortex-basal-ganglia circuits of movement disorders patients

Parkinson's syndrome affects millions worldwide, causing movement disorders such as slowness, tremors, and gait instability. Over 70% of patients also experience sensory disturbances, including pain, abnormal sensations, loss of smell, visual impairments, and hallucinations. These significantly reduce quality of life, yet effective treatments are still lacking. This research project aims to precisely map the underlying brain networks.

Thrombotic complications after viral infections – the role of antibodies against platelet factor 4

Viral infections can lead to a misdirected autoimmune response, in which the antibodies attack the own body (called anti-PF4 antibodies). They activate blood platelets and trigger life-threatening blood clots, e.g. in the brain. People of all ages can be affected, from young children to the elderly. Patients need to be diagnosed as quickly as possible to rapidly start treatment. This project aims to identify the mechanisms of disease development at a molecular level.